UY34565A - Ácidos 3-[4-(fenilaminooxalilamino)fenil]hex-4-inoicos, procedimiento para su preparación y uso de los mismos como un medicamento. - Google Patents

Ácidos 3-[4-(fenilaminooxalilamino)fenil]hex-4-inoicos, procedimiento para su preparación y uso de los mismos como un medicamento.

Info

Publication number
UY34565A
UY34565A UY0001034565A UY34565A UY34565A UY 34565 A UY34565 A UY 34565A UY 0001034565 A UY0001034565 A UY 0001034565A UY 34565 A UY34565 A UY 34565A UY 34565 A UY34565 A UY 34565A
Authority
UY
Uruguay
Prior art keywords
phenylaminooxylamino
inoic
hex
medicine
phenyl
Prior art date
Application number
UY0001034565A
Other languages
English (en)
Inventor
Dr Guenter Billen
Dr Elisabeth Defossa
Dr Viktoria Dietrich
Dr Thomas Klabunde
Dr Stefanie Keil
Dr Siegfried Stengelin
Dr Guido Haschke
Dr Andreas Herling
Dr Johanna Kuhlmann-Gottke
Dr Stefan Bartoschek
Dr Simon Gessler
Dr Angela Dudda
Dr Thomas Olpp
Dr Joerg Rieke-Zapp
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of UY34565A publication Critical patent/UY34565A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/56Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl groups, e.g. oxamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines

Abstract

La invención se refiere a ácidos 3-[4-(fenilaminooxalilamino)fenil]hex-4-inoicos y a sales fisiológicamente compatibles de los mismos. La invención se refiere a compuestos de la fórmula Ien la que R1, R2, R3 y R4 se define cada uno según se especifica, y a sales fisiológicamente compatibles de los mismos. Los compuestos son adecuados, por ejemplo, para el tratamiento de diabetes.
UY0001034565A 2012-01-04 2013-01-04 Ácidos 3-[4-(fenilaminooxalilamino)fenil]hex-4-inoicos, procedimiento para su preparación y uso de los mismos como un medicamento. UY34565A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305008 2012-01-04
US201261669440P 2012-07-09 2012-07-09
EP12306086 2012-09-10

Publications (1)

Publication Number Publication Date
UY34565A true UY34565A (es) 2013-09-02

Family

ID=48695298

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034565A UY34565A (es) 2012-01-04 2013-01-04 Ácidos 3-[4-(fenilaminooxalilamino)fenil]hex-4-inoicos, procedimiento para su preparación y uso de los mismos como un medicamento.

Country Status (4)

Country Link
US (1) US20130172248A1 (es)
EP (1) EP2800736A1 (es)
UY (1) UY34565A (es)
WO (1) WO2013102626A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015084692A1 (en) 2013-12-04 2015-06-11 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
WO2015119899A1 (en) 2014-02-06 2015-08-13 Merck Sharp & Dohme Corp. Antidiabetic compounds
US10710986B2 (en) 2018-02-13 2020-07-14 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
JP7242702B2 (ja) 2018-04-19 2023-03-20 ギリアード サイエンシーズ, インコーポレイテッド Pd-1/pd-l1阻害剤
UA126421C2 (uk) 2018-07-13 2022-09-28 Гіліад Сайєнсіз, Інк. Інгібітори pd-1/pd-l1
CN112955435A (zh) 2018-10-24 2021-06-11 吉利德科学公司 Pd-1/pd-l1抑制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011010B1 (ru) * 2004-02-27 2008-12-30 Эмджен, Инк. Соединения, модулирующие рецептор gpr40, фармацевтическая композиция, способ лечения заболеваний, чувствительных к модулированию рецептора gpr40 (варианты), способ модулирования функции gpr40 (варианты) и способ модулирования циркулирующей концентрации инсулина
EP2203416B1 (de) * 2007-09-21 2016-10-26 Sanofi (carboxylalkylen-phenyl)-phenyl-oxalamide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
EP2800736A1 (en) 2014-11-12
US20130172248A1 (en) 2013-07-04
WO2013102626A1 (en) 2013-07-11

Similar Documents

Publication Publication Date Title
UY34765A (es) Compuestos novedosos.
UY34104A (es) ?compuestos derivados benzamídicos heterocíclicos, procesos e intermedios para su preparación, composiciones y métodos para su uso?.
UY34374A (es) Benzilindazoles sustituidos
UY34648A (es) Amidas como inhibidores de pim
CL2014001765A1 (es) Proceso para la fabricacion de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina.
UY34515A (es) Triazolopiridinas sustituidas
UY34697A (es) Métodos para preparar análogos de nucleótidos
UY34559A (es) Inhibidores de bromodominios
UY34669A (es) COMPUESTOS EN BASE A IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y MÉTODOS PARA SU USO.
UY34668A (es) COMPUESTOS EN BASE A PIRAZOLO[1,5-a]PIRIMIDINA, COMPOSICIONES QUE LOS COMPRENDEN Y MÉTODOS PARA SU USO.
UY34492A (es) Método para preparar un componente de lignina, un componente de lignina y su uso y un producto
UY34778A (es) ?COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2-AMINA HETEROCÍCLICOS SUSTITUÍDOS?.
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
UY34302A (es) COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2- AMINA
UY33978A (es) Piridinonas bicíclicas nuevas.
UY34817A (es) Tienopirimidinas
UY34034A (es) Triazolopiridinas
UY4149Q (es) Golosina para mascota
UY34467A (es) Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
UY34006A (es) Imidazopiridazinas
CO7200270A2 (es) Azaindolcarboxamidas y azaindoltiocarboxamidas como insecticidas y acaricidas
UY34565A (es) Ácidos 3-[4-(fenilaminooxalilamino)fenil]hex-4-inoicos, procedimiento para su preparación y uso de los mismos como un medicamento.
UY34097A (es) Alineación de anticoagulante de cebado para extracción de sangre.
UY34730A (es) Formulaciones farmacéuticas que comprenden antagonistas de ccr3
UY34329A (es) Compuestos de triazolopiridina